UY23397A1 - Composicion y metodo de pro-droga de 5-fluorouracilo topica - Google Patents

Composicion y metodo de pro-droga de 5-fluorouracilo topica

Info

Publication number
UY23397A1
UY23397A1 UY23397A UY23397A UY23397A1 UY 23397 A1 UY23397 A1 UY 23397A1 UY 23397 A UY23397 A UY 23397A UY 23397 A UY23397 A UY 23397A UY 23397 A1 UY23397 A1 UY 23397A1
Authority
UY
Uruguay
Prior art keywords
pro
fluorouracil
composition
drug
topical
Prior art date
Application number
UY23397A
Other languages
English (en)
Inventor
B Sloan Kenneth
D Beall Howard
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of UY23397A1 publication Critical patent/UY23397A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describe una composición farmacéutica en forma de dosis unitaria adaptada para la administración tópica a un ser humano o a un animal que la necesita que comprende una cantidad farmacológicamente efectiva de una pro-droga de 5-fluorouracilo que tiene la fórmula de la figura 1 en la cual R1 y R2 pueden ser iguales o diferentes y se seleccionan de por ejemplo R3CO- con la condición de que ambos R1 y R2 no pueden ser H; o una sal, aducto, óxido y otro derivado de la misma no tóxico farmaceuticamente adecuado; y un portador para la misma farmaceuticamente aceptable, administrable tópicamente; comprendiendo dichos R3 y R4 grupos tales que dicha pro-droga (1) tiene una entrega mejorada a través de membranas tópicas de dicho animal o ser humano al aplicarse tópicamente dicha composición en comparación con 5-fluorouracilo, y (2) se hidroliza luego de la entrega a través de dicha membrana tópica para rendir una cantidad farmacológicamente efectiva de 5-fluorouracilo.
UY23397A 1991-04-05 1992-04-06 Composicion y metodo de pro-droga de 5-fluorouracilo topica UY23397A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68094591A 1991-04-05 1991-04-05

Publications (1)

Publication Number Publication Date
UY23397A1 true UY23397A1 (es) 1993-04-21

Family

ID=24733158

Family Applications (1)

Application Number Title Priority Date Filing Date
UY23397A UY23397A1 (es) 1991-04-05 1992-04-06 Composicion y metodo de pro-droga de 5-fluorouracilo topica

Country Status (8)

Country Link
US (1) US5610160A (es)
AU (1) AU1772792A (es)
CA (1) CA2065083A1 (es)
IE (1) IE921077A1 (es)
IL (1) IL101499A0 (es)
PT (1) PT100351A (es)
UY (1) UY23397A1 (es)
WO (1) WO1992017180A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
CN102229571B (zh) * 2011-05-11 2013-05-08 温州大学 一种5-氟尿嘧啶类药物中间体及其制备方法和应用
CA3088709A1 (en) * 2018-01-18 2019-07-25 Taro Pharmaceutical Industries Ltd. Topical capecitabine for the treatment of hyperproliferative skin conditions
TW202227401A (zh) * 2020-10-23 2022-07-16 大陸商重慶兩江藥物研發中心有限公司 用於持續釋放治療劑的前藥及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411893A (en) * 1981-08-14 1983-10-25 Minnesota Mining And Manufacturing Company Topical medicament preparations
US4845081A (en) * 1984-10-18 1989-07-04 University Of Florida Aminomethyl derivatives of biologically active substances, and enhanced delivery thereof across topical membranes
US4853388A (en) * 1987-05-15 1989-08-01 Pearlman Dale L Method for treating psoriasis with cytotoxic agents

Also Published As

Publication number Publication date
CA2065083A1 (en) 1992-10-06
WO1992017180A1 (en) 1992-10-15
US5610160A (en) 1997-03-11
AU1772792A (en) 1992-11-02
IE921077A1 (en) 1992-10-07
PT100351A (pt) 1993-07-30
IL101499A0 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
NO963053L (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
FI970164A (fi) Inhalaatioformula
ES2114569T3 (es) Sistema mejorado de penetracion en la piel para la administracion topica mejorada de farmacos.
MY174339A (en) 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions
DE69705300D1 (de) Cyclopropylalkansäurederivate
AR006598A1 (es) "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
KR890005124A (ko) 세펨 화합물 및 이의 제조방법
ATE171066T1 (de) Pharmazeutische zubereitungen mit einem wirkstoff, der modifizierte amidingruppen enthält
CL2004000304A1 (es) Uso del acido 4-[1-hidroxi-4-[4-hidroxidifenilmetil)-1-piperidinil]butil]-alfa, alfa-dimetilbenceno acetico o una sal farmaceuticamente aceptable del mismo, para la preparacion de un medicamento util como antihistaminico, en pacientes que padecen un
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
DE69928806D1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
UY23397A1 (es) Composicion y metodo de pro-droga de 5-fluorouracilo topica
DK0609336T3 (da) Anvendelse af prostacyclin-derivater til forebyggelse eller behandling af lidelser i mikrocirkulationssystemet ved administ
ES427079A1 (es) Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7.
KR910700230A (ko) 신규 히드록실아민 유도체
BG103958A (en) Pharmaceutical compositions of thioxanide and nitazoxanide
ZA845931B (en) 1-(4'-alkylsulphonylphenyl)-2-amino-1,3-propanediol n-substituted derivatives
ES2194412T3 (es) Uso de derivados de hidantoina para la preparacion de un medicamento para el tratamiento de vasculitis resistente al tratamiento.
KR960700711A (ko) 뇌혈관성 질환의 치료 또는 예방용 약제(Medicament for treating or preventing cerebrovascular diseases)
ES2194899T3 (es) Composicion farmaceutica para administracion transdermica sistemica del principio activo morfina-6-glucuronido.
GB1351437A (en) N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
KR950008502A (ko) 3-또는4-클리코실옥시벤조피란 유도체 및 활성 성분으로서 이를 함유하는 알러지치료제